Tuesday, July 12, 2016

UPDATE 1-Shire on a roll as U.S. approves keenly awaited eye drug

* Analysts see potential sales of $1 billion or more

(Adds analyst comments, shares, background)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)